FHIR IG analytics| Package | silfhirprofileig |
| Resource Type | ValueSet |
| Id | ValueSet-anti-cancer-therapy.json |
| FHIR Version | R5 |
| Source | https://build.fhir.org/ig/savannahghi/sil_fhir_profile_ig/ValueSet-anti-cancer-therapy.html |
| URL | https://fhir.slade360.co.ke/fhir/ValueSet/anti-cancer-therapy |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-10-02T07:33:51+00:00 |
| Name | SGHIAntiCancerTherapy |
| Title | SGHI Systemic Anti-Cancer Therapy |
| Description | The kinds of systemic anti-cancer therapy the cancer centre informed consent covers: chemotherapy, hormonal therapy and targeted therapy. The paper prints them as one line to strike through; this asks which apply, and more than one can. |
No resources found
| CodeSystem | ||
| silfhirprofileig#current | answer-codesystem | SGHI Answer Code System |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet anti-cancer-therapy
FHIR
FHIRsmithhttps://fhir.slade360.co.ke/fhir/CodeSystem/answer-codesystem version 📦0.1.0| Code | Display | Definition |
| anti-cancer-chemotherapy | Chemotherapy | Cytotoxic chemotherapy. Recorded on the cancer centre informed consent. |
| anti-cancer-hormonal-therapy | Hormonal therapy | Hormonal therapy, such as an LHRH agonist, an anti-androgen, an anti-oestrogen or an aromatase inhibitor. Recorded on the cancer centre informed consent. |
| anti-cancer-targeted-therapy | Targeted therapy | Targeted therapy against a molecular feature of the cancer, such as a HER2 antibody or a tyrosine kinase inhibitor. Recorded on the cancer centre informed consent. |
{
"resourceType": "ValueSet",
"id": "anti-cancer-therapy",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"url": "https://fhir.slade360.co.ke/fhir/ValueSet/anti-cancer-therapy",
"version": "0.1.0",
"name": "SGHIAntiCancerTherapy",
"title": "SGHI Systemic Anti-Cancer Therapy",
"status": "active",
"experimental": false,
"date": "2026-10-02T07:33:51+00:00",
"publisher": "Kathurima Kimathi",
"contact": [
{
"name": "Kathurima Kimathi",
"telecom": [
{
"system": "url",
"value": "https://www.linkedin.com/in/kathurima-kimathi/"
},
{
"system": "email",
"value": "kathurimakimathi415@gmail.com"
}
]
},
{
"name": "Oscar John",
"telecom": [
{
"system": "email",
"value": "oscarjohnotieno@gmail.com",
"use": "work"
}
]
},
{
"name": "Kennedy Omondi",
"telecom": [
{
"system": "email",
"value": "kennankole@gmail.com",
"use": "work"
}
]
}
],
"description": "The kinds of systemic anti-cancer therapy the cancer centre informed consent covers: chemotherapy, hormonal therapy and targeted therapy. The paper prints them as one line to strike through; this asks which apply, and more than one can.",
"compose": {
"include": [
{
"system": "https://fhir.slade360.co.ke/fhir/CodeSystem/answer-codesystem",
"concept": [
{
"code": "anti-cancer-chemotherapy",
"display": "Chemotherapy"
},
{
"code": "anti-cancer-hormonal-therapy",
"display": "Hormonal therapy"
},
{
"code": "anti-cancer-targeted-therapy",
"display": "Targeted therapy"
}
]
}
]
}
}